A single European currency for EQ-5D health states. Results from a six-country study
- PMID: 15609189
- DOI: 10.1007/s10198-003-0182-5
A single European currency for EQ-5D health states. Results from a six-country study
Abstract
The EQ-5D questionnaire is a widely used generic instrument for describing and valuing health that was developed by the EuroQol Group. A primary objective of the EuroQol Group is the investigation of values for health states in the general population in different countries. As part of the EuroQol enterprise 11 population surveys were carried out in six Western European countries (Finland, Germany, The Netherlands, Spain, Sweden and the UK) to value health states as defined by the EQ-5D using a standardised visual analogue scale (EQ-5D VAS). This contribution reports how a European set of general population preference weights was derived from the data collected in the 11 valuation studies. The scores from this set of preference weights can be applied to generate a VAS-based weighted health status index for all the potential 243 EQ-5D health states for use in multi-national studies. To estimate the preference weights a multi-level regression analysis was performed on 82,910 valuations of 44 EQ-5D health states elicited from 6,870 respondents. Stable and plausible solutions were found for the model parameters. The R(2) value was 75%. The analysis showed that the major source of variance, apart from 'random error', was variance between individuals (28.3% of the total residual variance). These results suggest that VAS values for EQ-5D health states in six Western European countries can be described by a common model.
Similar articles
-
Comparison of population health status in six european countries: results of a representative survey using the EQ-5D questionnaire.Med Care. 2009 Feb;47(2):255-61. doi: 10.1097/MLR.0b013e318184759e. Med Care. 2009. PMID: 19169128
-
Comparison of different valuation methods for population health status measured by the EQ-5D in three European countries.Value Health. 2009 Jul-Aug;12(5):750-8. doi: 10.1111/j.1524-4733.2009.00509.x. Value Health. 2009. PMID: 19490564
-
A social preference valuations set for EQ-5D health states in Flanders, Belgium.Eur J Health Econ. 2010 Apr;11(2):205-13. doi: 10.1007/s10198-009-0167-0. Epub 2009 Jul 7. Eur J Health Econ. 2010. PMID: 19582490
-
The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus.Diabet Med. 2011 Apr;28(4):395-413. doi: 10.1111/j.1464-5491.2010.03136.x. Diabet Med. 2011. PMID: 21392061 Review.
-
EQ-5D: a measure of health status from the EuroQol Group.Ann Med. 2001 Jul;33(5):337-43. doi: 10.3109/07853890109002087. Ann Med. 2001. PMID: 11491192 Review.
Cited by
-
What if 0 is not equal to 0? Inter-personal health utilities anchoring using the largest health gains.Eur J Health Econ. 2023 Sep;24(7):1217-1233. doi: 10.1007/s10198-022-01537-8. Epub 2022 Nov 8. Eur J Health Econ. 2023. PMID: 36344630 Free PMC article.
-
Economic evaluation of obinutuzumab in combination with chlorambucil in first-line treatment of patients with chronic lymphocytic leukemia in Spain.Clinicoecon Outcomes Res. 2016 Sep 21;8:475-484. doi: 10.2147/CEOR.S114524. eCollection 2016. Clinicoecon Outcomes Res. 2016. PMID: 27703384 Free PMC article.
-
Assessment of the age-specific disability weight of chronic schistosomiasis japonica.Bull World Health Organ. 2007 Jun;85(6):458-65. doi: 10.2471/blt.06.033035. Bull World Health Organ. 2007. PMID: 17639243 Free PMC article.
-
Taking steps towards deinstitutionalizing mental health care within a low and middle-income country: A cross-sectional study of service user needs in the Republic of Moldova.Int J Soc Psychiatry. 2020 Feb;66(1):49-57. doi: 10.1177/0020764019879951. Epub 2019 Oct 11. Int J Soc Psychiatry. 2020. PMID: 31603368 Free PMC article.
-
An economic evaluation of fluvastatin used for the prevention of cardiac events following successful first percutaneous coronary intervention in the UK.Pharmacoeconomics. 2004;22(8):525-35. doi: 10.2165/00019053-200422080-00004. Pharmacoeconomics. 2004. PMID: 15217308 Clinical Trial.
LinkOut - more resources
Other Literature Sources
Medical
Research Materials